Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of a synthetic Haemophilus influenzae type b conjugate vaccine
CTR20210935Phase 3Active
- Sponsor
- ChangHeber
- Start
- May 2021
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Haemophilus b conjugate vaccine in Haemophilus influenzae type b disease (Hib), sponsored by ChangHeber. Started May 2021; status: active.
02
Drugs
Haemophilus b conjugate vaccine
03
Conditions
Haemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on CTR20210935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210935.